Maze Therapeutics, a kidney disease therapy developer, recently IPO-ed with a market cap of $487mn and significant early-stage investor backing. Lead asset MZE829 targets APOL1 Kidney Disease, showing ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Belite Bio's lead drug, Tinlarebant, targets eye diseases STGD1 and GA, showing promising results but with delayed phase 3 trial data expected by late 2024 or early 2025. Tinlarebant works by reducing ...

If we invest more in AI as we both know public opinion in polling seems to be shifting strongly against I. I may end up being ...

The second installment is about synthetic resins and cellulose.Long time no see, everyone. I would like to talk about another interesting science topic. This time, it is about chemical substances ...

Talk about a bizarre feature of the human body: If you happened to swallow a razor blade, your stomach acid would dissolve it. Acids are ranked on a scale from zero to 14—the lower the pH level, the ...

The biosynthesis of the great variety of natural plant products has not yet been elucidated for many medically interesting substances. In a new study, an international team of researchers was able to ...

Graphic showing the different ways that numerical data is expressed in different cultures (Barbican Centre).Image by Tim Sandle. When assessing scientific rigor in terms of numbers and patterns, it is ...

Science has been molded along the years by man's intrinsic curiosity and need to understand what is happening around him. It has germinated from our necessity to comprehend how things work and to ...

The new moon on February 17 marks the start of the Lunar New Year, which is celebrated in many Southeast and East Asian countries. According to the Chinese zodiac, it’s also the start of the Year of ...